Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKL15508 in stable schizophrenia
NCT02205099Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Jul 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SKL15508 in schizophrenia, sponsored by SK Life Science, Inc.. Started Jul 2014; status: completed.
02
Drugs
SKL15508
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02205099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205099.